Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-17

Clinical Trial Update: Safety and Efficacy Study of Hydromorphone Hydrochloride by Intrathecal Administration [Phase 3]

View source ↗

Summary

Phase 3 trial update for intrathecal hydromorphone hydrochloride in chronic pain management with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydromorphone hydrochloride (hydromorphone hydrochloride)

Snippet

Sponsor: Piramal Critical Care, Ltd. | Conditions: Management of Chronic Pain | Phase 3 | Status: COMPLETED | Results posted: 2021-08-17